Evaluation of Cardiac Structural Changes Induced by Carbamazepine-Based Nanotherapeutics in an Experimental Epilepsy

Adem Tokpınar1, Hasan İlhan2, Semih Tan3

  • 1Department of Anatomy, Faculty of Medicine, Ordu University, Ordu 52000, Türkiye.

PubMed

Insights

Epilepsy induced by pentylenetetrazol (PTZ) caused heart damage in rats, but treatments with carbamazepine (CBZ) nanoparticles largely preserved cardiac tissue structure. This study explored novel nanoparticle coatings for potential therapeutic applications.

Area of Science:

  • Cardiovascular Research
  • Neuroscience
  • Nanomedicine

Background:

  • Experimental epilepsy models are crucial for understanding neurological disorders.
  • Carbamazepine (CBZ) is an antiepileptic drug with potential cardiac side effects.
  • Nanoparticle drug delivery systems offer novel therapeutic strategies.

Purpose of the Study:

  • To investigate the cardiac morphological effects of CBZ coated with carbon nanodots functionalized with silver nanoparticles (CNDs@AgNPs) and metal-organic framework (MOF-5) nanoparticles in rats with experimental epilepsy.
  • To evaluate histopathological and biochemical changes in cardiac tissue.
  • To assess the protective potential of these nanoparticle-drug conjugates against epilepsy-induced cardiotoxicity.

Main Methods:

  • Seventy male Wistar rats were induced with experimental epilepsy using pentylenetetrazol (PTZ).
  • Animals were divided into ten groups, receiving different treatments including CBZ, CNDs@AgNPs, and CNDs@MOF-5.
  • Cardiac tissues were analyzed using Haematoxylin-eosin staining, and levels of interleukin-6 (IL-6), catalase (CAT), and oxidative stress index (OSI) were determined biochemically.

Main Results:

  • PTZ-induced epilepsy led to significant histopathological changes, including pyknotic nuclei and hemorrhagic areas in cardiac tissue.
  • Cardiac tissue structure was largely preserved in groups treated with CBZ-coated nanoparticles.
  • Specific nanoparticle formulations showed variations in cardiac morphology measurements, such as atrial distance and apex-to-base length.

Conclusions:

  • PTZ-induced epilepsy causes notable cardiac histopathological alterations.
  • Carbamazepine coated with CNDs@AgNPs and CNDs@MOF-5 nanoparticles demonstrated a protective effect on cardiac tissue structure.
  • This study presents novel findings on the cardioprotective potential of nanoparticle-drug conjugates in an experimental epilepsy model.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.1K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
613